世界のA型肝炎ウイルス細胞受容体2市場インサイト及び予測(~2026年)

【英語タイトル】Global Hepatitis A Virus Cellular Receptor 2 Market Insights and Forecast to 2026

QYResearchが出版した調査資料(QYR20NV01125)・商品コード:QYR20NV01125
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:112
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートはA型肝炎ウイルス細胞受容体2の世界市場について調査・分析した資料です。種類別(IMM-1802、LY-3321367、MCLA-134、CA-170、CA-327、ENUM-005、その他)の市場規模、用途別(結腸がん、骨髄異形成症候群、非小細胞肺がん、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別A型肝炎ウイルス細胞受容体2の競争状況、市場シェア
・世界のA型肝炎ウイルス細胞受容体2市場:種類別市場規模 2015年-2020年(IMM-1802、LY-3321367、MCLA-134、CA-170、CA-327、ENUM-005、その他)
・世界のA型肝炎ウイルス細胞受容体2市場:種類別市場規模予測 2021年-2026年(IMM-1802、LY-3321367、MCLA-134、CA-170、CA-327、ENUM-005、その他)
・世界のA型肝炎ウイルス細胞受容体2市場:用途別市場規模 2015年-2020年(結腸がん、骨髄異形成症候群、非小細胞肺がん、その他)
・世界のA型肝炎ウイルス細胞受容体2市場:用途別市場規模予測 2021年-2026年(結腸がん、骨髄異形成症候群、非小細胞肺がん、その他)
・北米のA型肝炎ウイルス細胞受容体2市場分析:米国、カナダ
・ヨーロッパのA型肝炎ウイルス細胞受容体2市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのA型肝炎ウイルス細胞受容体2市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のA型肝炎ウイルス細胞受容体2市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのA型肝炎ウイルス細胞受容体2市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Aurigene Discovery Technologies Ltd、BeiGene Ltd、Eli Lilly and Co、Enumeral Biomedical Holdings Inc、Incyte Corp、Interprotein Corp、Jounce Therapeutics Inc、Merus NV、Novartis AG、Sorrento Therapeutics Inc、Sutro Biopharma Inc、Tesaro Inc、Trellis Bioscience Inc
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Hepatitis A Virus Cellular Receptor 2 Market
The global Hepatitis A Virus Cellular Receptor 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Hepatitis A Virus Cellular Receptor 2 Scope and Market Size
Hepatitis A Virus Cellular Receptor 2 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis A Virus Cellular Receptor 2 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Hepatitis A Virus Cellular Receptor 2 market is segmented into
IMM-1802
LY-3321367
MCLA-134
CA-170
CA-327
ENUM-005
Others

Segment by Application, the Hepatitis A Virus Cellular Receptor 2 market is segmented into
Colon Cancer
Myelodysplastic
Non-Small Cell Lung Cancer
Others

Regional and Country-level Analysis
The Hepatitis A Virus Cellular Receptor 2 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Hepatitis A Virus Cellular Receptor 2 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hepatitis A Virus Cellular Receptor 2 Market Share Analysis
Hepatitis A Virus Cellular Receptor 2 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hepatitis A Virus Cellular Receptor 2 business, the date to enter into the Hepatitis A Virus Cellular Receptor 2 market, Hepatitis A Virus Cellular Receptor 2 product introduction, recent developments, etc.

The major vendors covered:
Aurigene Discovery Technologies Ltd
BeiGene Ltd
Eli Lilly and Co
Enumeral Biomedical Holdings Inc
Incyte Corp
Interprotein Corp
Jounce Therapeutics Inc
Merus NV
Novartis AG
Sorrento Therapeutics Inc
Sutro Biopharma Inc
Tesaro Inc
Trellis Bioscience Inc

【レポートの目次】

1 Study Coverage
1.1 Hepatitis A Virus Cellular Receptor 2 Product Introduction
1.2 Market Segments
1.3 Key Hepatitis A Virus Cellular Receptor 2 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate by Type
1.4.2 IMM-1802
1.4.3 LY-3321367
1.4.4 MCLA-134
1.4.5 CA-170
1.4.6 CA-327
1.4.7 ENUM-005
1.4.8 Others
1.5 Market by Application
1.5.1 Global Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate by Application
1.5.2 Colon Cancer
1.5.3 Myelodysplastic
1.5.4 Non-Small Cell Lung Cancer
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Hepatitis A Virus Cellular Receptor 2 Market Size, Estimates and Forecasts
2.1.1 Global Hepatitis A Virus Cellular Receptor 2 Revenue 2015-2026
2.1.2 Global Hepatitis A Virus Cellular Receptor 2 Sales 2015-2026
2.2 Global Hepatitis A Virus Cellular Receptor 2, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Hepatitis A Virus Cellular Receptor 2 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hepatitis A Virus Cellular Receptor 2 Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Hepatitis A Virus Cellular Receptor 2 Competitor Landscape by Players
3.1 Hepatitis A Virus Cellular Receptor 2 Sales by Manufacturers
3.1.1 Hepatitis A Virus Cellular Receptor 2 Sales by Manufacturers (2015-2020)
3.1.2 Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Manufacturers (2015-2020)
3.2 Hepatitis A Virus Cellular Receptor 2 Revenue by Manufacturers
3.2.1 Hepatitis A Virus Cellular Receptor 2 Revenue by Manufacturers (2015-2020)
3.2.2 Hepatitis A Virus Cellular Receptor 2 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hepatitis A Virus Cellular Receptor 2 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hepatitis A Virus Cellular Receptor 2 Revenue in 2019
3.2.5 Global Hepatitis A Virus Cellular Receptor 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hepatitis A Virus Cellular Receptor 2 Price by Manufacturers
3.4 Hepatitis A Virus Cellular Receptor 2 Manufacturing Base Distribution, Product Types
3.4.1 Hepatitis A Virus Cellular Receptor 2 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hepatitis A Virus Cellular Receptor 2 Product Type
3.4.3 Date of International Manufacturers Enter into Hepatitis A Virus Cellular Receptor 2 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2015-2020)
4.1.1 Global Hepatitis A Virus Cellular Receptor 2 Sales by Type (2015-2020)
4.1.2 Global Hepatitis A Virus Cellular Receptor 2 Revenue by Type (2015-2020)
4.1.3 Hepatitis A Virus Cellular Receptor 2 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hepatitis A Virus Cellular Receptor 2 Market Size Forecast by Type (2021-2026)
4.2.1 Global Hepatitis A Virus Cellular Receptor 2 Sales Forecast by Type (2021-2026)
4.2.2 Global Hepatitis A Virus Cellular Receptor 2 Revenue Forecast by Type (2021-2026)
4.2.3 Hepatitis A Virus Cellular Receptor 2 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hepatitis A Virus Cellular Receptor 2 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2015-2020)
5.1.1 Global Hepatitis A Virus Cellular Receptor 2 Sales by Application (2015-2020)
5.1.2 Global Hepatitis A Virus Cellular Receptor 2 Revenue by Application (2015-2020)
5.1.3 Hepatitis A Virus Cellular Receptor 2 Price by Application (2015-2020)
5.2 Hepatitis A Virus Cellular Receptor 2 Market Size Forecast by Application (2021-2026)
5.2.1 Global Hepatitis A Virus Cellular Receptor 2 Sales Forecast by Application (2021-2026)
5.2.2 Global Hepatitis A Virus Cellular Receptor 2 Revenue Forecast by Application (2021-2026)
5.2.3 Global Hepatitis A Virus Cellular Receptor 2 Price Forecast by Application (2021-2026)

6 North America
6.1 North America Hepatitis A Virus Cellular Receptor 2 by Country
6.1.1 North America Hepatitis A Virus Cellular Receptor 2 Sales by Country
6.1.2 North America Hepatitis A Virus Cellular Receptor 2 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hepatitis A Virus Cellular Receptor 2 Market Facts & Figures by Type
6.3 North America Hepatitis A Virus Cellular Receptor 2 Market Facts & Figures by Application

7 Europe
7.1 Europe Hepatitis A Virus Cellular Receptor 2 by Country
7.1.1 Europe Hepatitis A Virus Cellular Receptor 2 Sales by Country
7.1.2 Europe Hepatitis A Virus Cellular Receptor 2 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hepatitis A Virus Cellular Receptor 2 Market Facts & Figures by Type
7.3 Europe Hepatitis A Virus Cellular Receptor 2 Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Hepatitis A Virus Cellular Receptor 2 by Region
8.1.1 Asia Pacific Hepatitis A Virus Cellular Receptor 2 Sales by Region
8.1.2 Asia Pacific Hepatitis A Virus Cellular Receptor 2 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hepatitis A Virus Cellular Receptor 2 Market Facts & Figures by Type
8.3 Asia Pacific Hepatitis A Virus Cellular Receptor 2 Market Facts & Figures by Application

9 Latin America
9.1 Latin America Hepatitis A Virus Cellular Receptor 2 by Country
9.1.1 Latin America Hepatitis A Virus Cellular Receptor 2 Sales by Country
9.1.2 Latin America Hepatitis A Virus Cellular Receptor 2 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hepatitis A Virus Cellular Receptor 2 Market Facts & Figures by Type
9.3 Central & South America Hepatitis A Virus Cellular Receptor 2 Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Hepatitis A Virus Cellular Receptor 2 by Country
10.1.1 Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Sales by Country
10.1.2 Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Market Facts & Figures by Type
10.3 Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Market Facts & Figures by Application

11 Company Profiles
11.1 Aurigene Discovery Technologies Ltd
11.1.1 Aurigene Discovery Technologies Ltd Corporation Information
11.1.2 Aurigene Discovery Technologies Ltd Description and Business Overview
11.1.3 Aurigene Discovery Technologies Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aurigene Discovery Technologies Ltd Hepatitis A Virus Cellular Receptor 2 Products Offered
11.1.5 Aurigene Discovery Technologies Ltd Related Developments
11.2 BeiGene Ltd
11.2.1 BeiGene Ltd Corporation Information
11.2.2 BeiGene Ltd Description and Business Overview
11.2.3 BeiGene Ltd Sales, Revenue and Gross Margin (2015-2020)
11.2.4 BeiGene Ltd Hepatitis A Virus Cellular Receptor 2 Products Offered
11.2.5 BeiGene Ltd Related Developments
11.3 Eli Lilly and Co
11.3.1 Eli Lilly and Co Corporation Information
11.3.2 Eli Lilly and Co Description and Business Overview
11.3.3 Eli Lilly and Co Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eli Lilly and Co Hepatitis A Virus Cellular Receptor 2 Products Offered
11.3.5 Eli Lilly and Co Related Developments
11.4 Enumeral Biomedical Holdings Inc
11.4.1 Enumeral Biomedical Holdings Inc Corporation Information
11.4.2 Enumeral Biomedical Holdings Inc Description and Business Overview
11.4.3 Enumeral Biomedical Holdings Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Enumeral Biomedical Holdings Inc Hepatitis A Virus Cellular Receptor 2 Products Offered
11.4.5 Enumeral Biomedical Holdings Inc Related Developments
11.5 Incyte Corp
11.5.1 Incyte Corp Corporation Information
11.5.2 Incyte Corp Description and Business Overview
11.5.3 Incyte Corp Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Incyte Corp Hepatitis A Virus Cellular Receptor 2 Products Offered
11.5.5 Incyte Corp Related Developments
11.6 Interprotein Corp
11.6.1 Interprotein Corp Corporation Information
11.6.2 Interprotein Corp Description and Business Overview
11.6.3 Interprotein Corp Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Interprotein Corp Hepatitis A Virus Cellular Receptor 2 Products Offered
11.6.5 Interprotein Corp Related Developments
11.7 Jounce Therapeutics Inc
11.7.1 Jounce Therapeutics Inc Corporation Information
11.7.2 Jounce Therapeutics Inc Description and Business Overview
11.7.3 Jounce Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Jounce Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Products Offered
11.7.5 Jounce Therapeutics Inc Related Developments
11.8 Merus NV
11.8.1 Merus NV Corporation Information
11.8.2 Merus NV Description and Business Overview
11.8.3 Merus NV Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Merus NV Hepatitis A Virus Cellular Receptor 2 Products Offered
11.8.5 Merus NV Related Developments
11.9 Novartis AG
11.9.1 Novartis AG Corporation Information
11.9.2 Novartis AG Description and Business Overview
11.9.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Novartis AG Hepatitis A Virus Cellular Receptor 2 Products Offered
11.9.5 Novartis AG Related Developments
11.10 Sorrento Therapeutics Inc
11.10.1 Sorrento Therapeutics Inc Corporation Information
11.10.2 Sorrento Therapeutics Inc Description and Business Overview
11.10.3 Sorrento Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Sorrento Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Products Offered
11.10.5 Sorrento Therapeutics Inc Related Developments
11.1 Aurigene Discovery Technologies Ltd
11.1.1 Aurigene Discovery Technologies Ltd Corporation Information
11.1.2 Aurigene Discovery Technologies Ltd Description and Business Overview
11.1.3 Aurigene Discovery Technologies Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aurigene Discovery Technologies Ltd Hepatitis A Virus Cellular Receptor 2 Products Offered
11.1.5 Aurigene Discovery Technologies Ltd Related Developments
11.12 Tesaro Inc
11.12.1 Tesaro Inc Corporation Information
11.12.2 Tesaro Inc Description and Business Overview
11.12.3 Tesaro Inc Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Tesaro Inc Products Offered
11.12.5 Tesaro Inc Related Developments
11.13 Trellis Bioscience Inc
11.13.1 Trellis Bioscience Inc Corporation Information
11.13.2 Trellis Bioscience Inc Description and Business Overview
11.13.3 Trellis Bioscience Inc Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Trellis Bioscience Inc Products Offered
11.13.5 Trellis Bioscience Inc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Hepatitis A Virus Cellular Receptor 2 Market Estimates and Projections by Region
12.1.1 Global Hepatitis A Virus Cellular Receptor 2 Sales Forecast by Regions 2021-2026
12.1.2 Global Hepatitis A Virus Cellular Receptor 2 Revenue Forecast by Regions 2021-2026
12.2 North America Hepatitis A Virus Cellular Receptor 2 Market Size Forecast (2021-2026)
12.2.1 North America: Hepatitis A Virus Cellular Receptor 2 Sales Forecast (2021-2026)
12.2.2 North America: Hepatitis A Virus Cellular Receptor 2 Revenue Forecast (2021-2026)
12.2.3 North America: Hepatitis A Virus Cellular Receptor 2 Market Size Forecast by Country (2021-2026)
12.3 Europe Hepatitis A Virus Cellular Receptor 2 Market Size Forecast (2021-2026)
12.3.1 Europe: Hepatitis A Virus Cellular Receptor 2 Sales Forecast (2021-2026)
12.3.2 Europe: Hepatitis A Virus Cellular Receptor 2 Revenue Forecast (2021-2026)
12.3.3 Europe: Hepatitis A Virus Cellular Receptor 2 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hepatitis A Virus Cellular Receptor 2 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hepatitis A Virus Cellular Receptor 2 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hepatitis A Virus Cellular Receptor 2 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hepatitis A Virus Cellular Receptor 2 Market Size Forecast by Region (2021-2026)
12.5 Latin America Hepatitis A Virus Cellular Receptor 2 Market Size Forecast (2021-2026)
12.5.1 Latin America: Hepatitis A Virus Cellular Receptor 2 Sales Forecast (2021-2026)
12.5.2 Latin America: Hepatitis A Virus Cellular Receptor 2 Revenue Forecast (2021-2026)
12.5.3 Latin America: Hepatitis A Virus Cellular Receptor 2 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hepatitis A Virus Cellular Receptor 2 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hepatitis A Virus Cellular Receptor 2 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hepatitis A Virus Cellular Receptor 2 Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Hepatitis A Virus Cellular Receptor 2 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hepatitis A Virus Cellular Receptor 2 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Hepatitis A Virus Cellular Receptor 2 Market Segments
Table 2. Ranking of Global Top Hepatitis A Virus Cellular Receptor 2 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of IMM-1802
Table 5. Major Manufacturers of LY-3321367
Table 6. Major Manufacturers of MCLA-134
Table 7. Major Manufacturers of CA-170
Table 8. Major Manufacturers of CA-327
Table 9. Major Manufacturers of ENUM-005
Table 10. Major Manufacturers of Others
Table 11. Global Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 12. Global Hepatitis A Virus Cellular Receptor 2 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 13. Global Hepatitis A Virus Cellular Receptor 2 Sales by Regions 2015-2020 (K Pcs)
Table 14. Global Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Regions (2015-2020)
Table 15. Global Hepatitis A Virus Cellular Receptor 2 Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Hepatitis A Virus Cellular Receptor 2 Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Hepatitis A Virus Cellular Receptor 2 Sales Share by Manufacturers (2015-2020)
Table 18. Global Hepatitis A Virus Cellular Receptor 2 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Hepatitis A Virus Cellular Receptor 2 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis A Virus Cellular Receptor 2 as of 2019)
Table 20. Hepatitis A Virus Cellular Receptor 2 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Hepatitis A Virus Cellular Receptor 2 Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Hepatitis A Virus Cellular Receptor 2 Price (2015-2020) (USD/Pcs)
Table 23. Hepatitis A Virus Cellular Receptor 2 Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Hepatitis A Virus Cellular Receptor 2 Product Type
Table 25. Date of International Manufacturers Enter into Hepatitis A Virus Cellular Receptor 2 Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Hepatitis A Virus Cellular Receptor 2 Sales by Type (2015-2020) (K Pcs)
Table 28. Global Hepatitis A Virus Cellular Receptor 2 Sales Share by Type (2015-2020)
Table 29. Global Hepatitis A Virus Cellular Receptor 2 Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Hepatitis A Virus Cellular Receptor 2 Revenue Share by Type (2015-2020)
Table 31. Hepatitis A Virus Cellular Receptor 2 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Hepatitis A Virus Cellular Receptor 2 Sales by Application (2015-2020) (K Pcs)
Table 33. Global Hepatitis A Virus Cellular Receptor 2 Sales Share by Application (2015-2020)
Table 34. North America Hepatitis A Virus Cellular Receptor 2 Sales by Country (2015-2020) (K Pcs)
Table 35. North America Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Country (2015-2020)
Table 36. North America Hepatitis A Virus Cellular Receptor 2 Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Country (2015-2020)
Table 38. North America Hepatitis A Virus Cellular Receptor 2 Sales by Type (2015-2020) (K Pcs)
Table 39. North America Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Type (2015-2020)
Table 40. North America Hepatitis A Virus Cellular Receptor 2 Sales by Application (2015-2020) (K Pcs)
Table 41. North America Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Application (2015-2020)
Table 42. Europe Hepatitis A Virus Cellular Receptor 2 Sales by Country (2015-2020) (K Pcs)
Table 43. Europe Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Country (2015-2020)
Table 44. Europe Hepatitis A Virus Cellular Receptor 2 Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Country (2015-2020)
Table 46. Europe Hepatitis A Virus Cellular Receptor 2 Sales by Type (2015-2020) (K Pcs)
Table 47. Europe Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Type (2015-2020)
Table 48. Europe Hepatitis A Virus Cellular Receptor 2 Sales by Application (2015-2020) (K Pcs)
Table 49. Europe Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Hepatitis A Virus Cellular Receptor 2 Sales by Region (2015-2020) (K Pcs)
Table 51. Asia Pacific Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Hepatitis A Virus Cellular Receptor 2 Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Hepatitis A Virus Cellular Receptor 2 Sales by Type (2015-2020) (K Pcs)
Table 55. Asia Pacific Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Hepatitis A Virus Cellular Receptor 2 Sales by Application (2015-2020) (K Pcs)
Table 57. Asia Pacific Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Application (2015-2020)
Table 58. Latin America Hepatitis A Virus Cellular Receptor 2 Sales by Country (2015-2020) (K Pcs)
Table 59. Latin America Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Hepatitis A Virus Cellular Receptor 2 Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Country (2015-2020)
Table 62. Latin America Hepatitis A Virus Cellular Receptor 2 Sales by Type (2015-2020) (K Pcs)
Table 63. Latin America Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Type (2015-2020)
Table 64. Latin America Hepatitis A Virus Cellular Receptor 2 Sales by Application (2015-2020) (K Pcs)
Table 65. Latin America Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Sales by Country (2015-2020) (K Pcs)
Table 67. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Sales by Type (2015-2020) (K Pcs)
Table 71. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Sales by Application (2015-2020) (K Pcs)
Table 73. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Application (2015-2020)
Table 74. Aurigene Discovery Technologies Ltd Corporation Information
Table 75. Aurigene Discovery Technologies Ltd Description and Major Businesses
Table 76. Aurigene Discovery Technologies Ltd Hepatitis A Virus Cellular Receptor 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. Aurigene Discovery Technologies Ltd Product
Table 78. Aurigene Discovery Technologies Ltd Recent Development
Table 79. BeiGene Ltd Corporation Information
Table 80. BeiGene Ltd Description and Major Businesses
Table 81. BeiGene Ltd Hepatitis A Virus Cellular Receptor 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. BeiGene Ltd Product
Table 83. BeiGene Ltd Recent Development
Table 84. Eli Lilly and Co Corporation Information
Table 85. Eli Lilly and Co Description and Major Businesses
Table 86. Eli Lilly and Co Hepatitis A Virus Cellular Receptor 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. Eli Lilly and Co Product
Table 88. Eli Lilly and Co Recent Development
Table 89. Enumeral Biomedical Holdings Inc Corporation Information
Table 90. Enumeral Biomedical Holdings Inc Description and Major Businesses
Table 91. Enumeral Biomedical Holdings Inc Hepatitis A Virus Cellular Receptor 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Enumeral Biomedical Holdings Inc Product
Table 93. Enumeral Biomedical Holdings Inc Recent Development
Table 94. Incyte Corp Corporation Information
Table 95. Incyte Corp Description and Major Businesses
Table 96. Incyte Corp Hepatitis A Virus Cellular Receptor 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. Incyte Corp Product
Table 98. Incyte Corp Recent Development
Table 99. Interprotein Corp Corporation Information
Table 100. Interprotein Corp Description and Major Businesses
Table 101. Interprotein Corp Hepatitis A Virus Cellular Receptor 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. Interprotein Corp Product
Table 103. Interprotein Corp Recent Development
Table 104. Jounce Therapeutics Inc Corporation Information
Table 105. Jounce Therapeutics Inc Description and Major Businesses
Table 106. Jounce Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 107. Jounce Therapeutics Inc Product
Table 108. Jounce Therapeutics Inc Recent Development
Table 109. Merus NV Corporation Information
Table 110. Merus NV Description and Major Businesses
Table 111. Merus NV Hepatitis A Virus Cellular Receptor 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Merus NV Product
Table 113. Merus NV Recent Development
Table 114. Novartis AG Corporation Information
Table 115. Novartis AG Description and Major Businesses
Table 116. Novartis AG Hepatitis A Virus Cellular Receptor 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Novartis AG Product
Table 118. Novartis AG Recent Development
Table 119. Sorrento Therapeutics Inc Corporation Information
Table 120. Sorrento Therapeutics Inc Description and Major Businesses
Table 121. Sorrento Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 122. Sorrento Therapeutics Inc Product
Table 123. Sorrento Therapeutics Inc Recent Development
Table 124. Sutro Biopharma Inc Corporation Information
Table 125. Sutro Biopharma Inc Description and Major Businesses
Table 126. Sutro Biopharma Inc Hepatitis A Virus Cellular Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 127. Sutro Biopharma Inc Product
Table 128. Sutro Biopharma Inc Recent Development
Table 129. Tesaro Inc Corporation Information
Table 130. Tesaro Inc Description and Major Businesses
Table 131. Tesaro Inc Hepatitis A Virus Cellular Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 132. Tesaro Inc Product
Table 133. Tesaro Inc Recent Development
Table 134. Trellis Bioscience Inc Corporation Information
Table 135. Trellis Bioscience Inc Description and Major Businesses
Table 136. Trellis Bioscience Inc Hepatitis A Virus Cellular Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 137. Trellis Bioscience Inc Product
Table 138. Trellis Bioscience Inc Recent Development
Table 139. Global Hepatitis A Virus Cellular Receptor 2 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 140. Global Hepatitis A Virus Cellular Receptor 2 Sales Market Share Forecast by Regions (2021-2026)
Table 141. Global Hepatitis A Virus Cellular Receptor 2 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 142. Global Hepatitis A Virus Cellular Receptor 2 Revenue Market Share Forecast by Regions (2021-2026)
Table 143. North America: Hepatitis A Virus Cellular Receptor 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 144. North America: Hepatitis A Virus Cellular Receptor 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Europe: Hepatitis A Virus Cellular Receptor 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 146. Europe: Hepatitis A Virus Cellular Receptor 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Asia Pacific: Hepatitis A Virus Cellular Receptor 2 Sales Forecast by Region (2021-2026) (K Pcs)
Table 148. Asia Pacific: Hepatitis A Virus Cellular Receptor 2 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 149. Latin America: Hepatitis A Virus Cellular Receptor 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 150. Latin America: Hepatitis A Virus Cellular Receptor 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Middle East and Africa: Hepatitis A Virus Cellular Receptor 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 152. Middle East and Africa: Hepatitis A Virus Cellular Receptor 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 154. Key Challenges
Table 155. Market Risks
Table 156. Main Points Interviewed from Key Hepatitis A Virus Cellular Receptor 2 Players
Table 157. Hepatitis A Virus Cellular Receptor 2 Customers List
Table 158. Hepatitis A Virus Cellular Receptor 2 Distributors List
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatitis A Virus Cellular Receptor 2 Product Picture
Figure 2. Global Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Type in 2020 & 2026
Figure 3. IMM-1802 Product Picture
Figure 4. LY-3321367 Product Picture
Figure 5. MCLA-134 Product Picture
Figure 6. CA-170 Product Picture
Figure 7. CA-327 Product Picture
Figure 8. ENUM-005 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Application in 2020 & 2026
Figure 11. Colon Cancer
Figure 12. Myelodysplastic
Figure 13. Non-Small Cell Lung Cancer
Figure 14. Others
Figure 15. Hepatitis A Virus Cellular Receptor 2 Report Years Considered
Figure 16. Global Hepatitis A Virus Cellular Receptor 2 Market Size 2015-2026 (US$ Million)
Figure 17. Global Hepatitis A Virus Cellular Receptor 2 Sales 2015-2026 (K Pcs)
Figure 18. Global Hepatitis A Virus Cellular Receptor 2 Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Region (2015-2020)
Figure 20. Global Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Region in 2019
Figure 21. Global Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Region (2015-2020)
Figure 22. Global Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Region in 2019
Figure 23. Global Hepatitis A Virus Cellular Receptor 2 Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Hepatitis A Virus Cellular Receptor 2 Revenue in 2019
Figure 25. Hepatitis A Virus Cellular Receptor 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Type (2015-2020)
Figure 27. Global Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Type in 2019
Figure 28. Global Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Type (2015-2020)
Figure 29. Global Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Type in 2019
Figure 30. Global Hepatitis A Virus Cellular Receptor 2 Market Share by Price Range (2015-2020)
Figure 31. Global Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Application (2015-2020)
Figure 32. Global Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Application in 2019
Figure 33. Global Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Application (2015-2020)
Figure 34. Global Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Application in 2019
Figure 35. North America Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 36. North America Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Country in 2019
Figure 38. North America Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Country in 2019
Figure 39. U.S. Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. U.S. Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 42. Canada Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America Hepatitis A Virus Cellular Receptor 2 Market Share by Type in 2019
Figure 44. North America Hepatitis A Virus Cellular Receptor 2 Market Share by Application in 2019
Figure 45. Europe Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 46. Europe Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Country in 2019
Figure 48. Europe Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Country in 2019
Figure 49. Germany Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Germany Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. France Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. U.K. Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Italy Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. Russia Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe Hepatitis A Virus Cellular Receptor 2 Market Share by Type in 2019
Figure 60. Europe Hepatitis A Virus Cellular Receptor 2 Market Share by Application in 2019
Figure 61. Asia Pacific Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 62. Asia Pacific Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Region in 2019
Figure 64. Asia Pacific Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Region in 2019
Figure 65. China Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. China Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. South Korea Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. India Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Australia Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Taiwan Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Indonesia Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Thailand Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Malaysia Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Philippines Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Vietnam Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific Hepatitis A Virus Cellular Receptor 2 Market Share by Type in 2019
Figure 88. Asia Pacific Hepatitis A Virus Cellular Receptor 2 Market Share by Application in 2019
Figure 89. Latin America Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 90. Latin America Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Country in 2019
Figure 92. Latin America Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Country in 2019
Figure 93. Mexico Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Mexico Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Brazil Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 98. Argentina Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America Hepatitis A Virus Cellular Receptor 2 Market Share by Type in 2019
Figure 100. Latin America Hepatitis A Virus Cellular Receptor 2 Market Share by Application in 2019
Figure 101. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 102. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Country in 2019
Figure 104. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Country in 2019
Figure 105. Turkey Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Turkey Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. Saudi Arabia Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 110. U.A.E Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Market Share by Type in 2019
Figure 112. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Market Share by Application in 2019
Figure 113. North America Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. North America Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Europe Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Asia Pacific Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Latin America Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 122. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed


【掲載企業】

Aurigene Discovery Technologies Ltd、BeiGene Ltd、Eli Lilly and Co、Enumeral Biomedical Holdings Inc、Incyte Corp、Interprotein Corp、Jounce Therapeutics Inc、Merus NV、Novartis AG、Sorrento Therapeutics Inc、Sutro Biopharma Inc、Tesaro Inc、Trellis Bioscience Inc

★調査レポート[世界のA型肝炎ウイルス細胞受容体2市場インサイト及び予測(~2026年)] (コード:QYR20NV01125)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のA型肝炎ウイルス細胞受容体2市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆